Henry Y Shin, Ph.D. Email & Phone Number
@ouhsc.edu
LinkedIn matched
Who is Henry Y Shin, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Henry Y Shin, Ph.D. is listed as Co-Founder and CEO at Excitant Therapeutics, based in Oklahoma City, Oklahoma, United States. AeroLeads shows a work email signal at ouhsc.edu and a matched LinkedIn profile for Henry Y Shin, Ph.D..
Henry Y Shin, Ph.D. previously worked as Postdoctoral Researcher at University Of Oklahoma Health Sciences Center and Doctoral Candidate at University Of Oklahoma Health Sciences Center. Henry Y Shin, Ph.D. holds Doctor Of Philosophy (Ph.D.), Physiology from University Of Oklahoma Health Sciences Center.
Email format at Excitant Therapeutics
This section adds company-level context without repeating Henry Y Shin, Ph.D.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Henry Y Shin, Ph.D.. Compare company email patterns before reaching out.
About Henry Y Shin, Ph.D.
An ophthalmic researcher with 10+ years of experience leading basic & translational research projects on various ocular pathologies including Diabetic Retinopathy and Age-related Macular Degeneration. Enthusiastic about ophthalmic drug development with relevant industry experience that includes strategic planning of pre-clinical R&D roadmap, designing and execution of proof-of-concept studies, management of personnel, resource, and budget, and establishing multi-disciplinary teams to synergize and maximize pre-clinical R&D outcomes.
Listed skills include Molecular Biology, Pcr, Cell Biology, Sds Page, and 12 others.
Henry Y Shin, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Henry Y Shin, Ph.D. work experience
A career timeline built from the work history available for this profile.
Co-Founder And Ceo
Current● Founded Excitant Therapeutics LLC to develop and commercialize PPAR-α agonists as potential therapeutic agents for diabetic retinopathy and age-related macular degeneration● Acquired exclusive rights to develop and commercialize small molecule portfolios (US 11,337,968 B2 and US 11,447,452 B2)● Established a research laboratory, hired and managed human resources (2 Ph.D. scientists and 5 research staff, cumulative) and secured multiple Small Business Innovative Research grants from National Eye Institute worth ~$2.7M to advance small molecule compounds for diabetic retinopathy and age-related macular degeneration
Postdoctoral Researcher
● Collaborated on a multi-PI, Hit-to-lead & lead to optimization project to find a novel drug for diabetic retinopathy● Filed a provisional patent on novel PPAR-α agonists (US Provisional Patent application 62643998; Filed on March 2018) as a co-inventor● Acquired intramural seed funding ($75,000) to advance novel PPAR-α agonists further into commercialization● Got selected as an OK catalyst researcher (monetary award for young STEM-entrepreneurs in Oklahoma)● Collaborated on an academic project to evaluate NRLP3 inflammasome inhibitors for retinopathy of prematurity● Trained and mentored graduate students and research scholars
Doctoral Candidate
● Extensively trained on development, application and optimization of molecular tools and animal models to study various ocular diseases● Generated a knock-in mouse model of human RPE65 mutation, D477G, and performed a characterization study (published in American Journal of Pathology, 2016)● Evaluated a potent visual cycle inhibitor CU239 in a mouse model of retinal degeneration for its therapeutic potential (published in BBA Molecular Basis of Disease, 2018)● Generated RPE-specific knock-out mice for Rdh10 to evaluate its novel role in visual cycle (unpublished) ● Mentored high school students for summer research projects● Guided a hands-on molecular biology research project to clone a dual-expression vector system
Research Assistant
-Assisted an MD/PhD of Hematology/Oncology in developing gene screening strategies-Performed PCR and collected data for generation of G2E3 (ubiquitin ligase) conditional knock-out mice-Acquired various lab techniques essential in gene cloning and molecular biology research lab
Henry Y Shin, Ph.D. education
Doctor Of Philosophy (Ph.D.), Physiology
Bachelor Of Science (B.S.), Biology
Foundation Degree, Biology
Frequently asked questions about Henry Y Shin, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Henry Y Shin, Ph.D. work for?
Henry Y Shin, Ph.D. works for Excitant Therapeutics.
What is Henry Y Shin, Ph.D.'s role at Excitant Therapeutics?
Henry Y Shin, Ph.D. is listed as Co-Founder and CEO at Excitant Therapeutics.
What is Henry Y Shin, Ph.D.'s email address?
AeroLeads has found 1 work email signal at @ouhsc.edu for Henry Y Shin, Ph.D. at Excitant Therapeutics.
Where is Henry Y Shin, Ph.D. based?
Henry Y Shin, Ph.D. is based in Oklahoma City, Oklahoma, United States while working with Excitant Therapeutics.
What companies has Henry Y Shin, Ph.D. worked for?
Henry Y Shin, Ph.D. has worked for Excitant Therapeutics and University Of Oklahoma Health Sciences Center.
How can I contact Henry Y Shin, Ph.D.?
You can use AeroLeads to view verified contact signals for Henry Y Shin, Ph.D. at Excitant Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Henry Y Shin, Ph.D. attend?
Henry Y Shin, Ph.D. holds Doctor Of Philosophy (Ph.D.), Physiology from University Of Oklahoma Health Sciences Center.
What skills is Henry Y Shin, Ph.D. known for?
Henry Y Shin, Ph.D. is listed with skills including Molecular Biology, Pcr, Cell Biology, Sds Page, Cell Culture, Life Sciences, Science, and Chemistry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial